PAUL VARKI
CIK 1677896 · Chief Legal Officer · last filed 2026-05-26
PAUL VARKI is a Chief Legal Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for AVTX, was dated May 26, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $412.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$412.3K
2
12
-$1.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Chief Legal Officer | 27,934 | $14.76 | $412.3K | -$1.51M | 6 | 2026-05-26 |
| Zyla Life Sciences (EGLT) Delisted | SVP, GC & Chief Compliance Off | 29,514 | — | — | -$18.3K | 6 | 2017-07-06 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | AVTX | Grant (A) | +24,300 | $0 | EDGAR |
| 2026-05-07 | AVTX | Mixed | — | -$573.3K | EDGAR |
| 2026-03-02 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2025-12-12 | AVTX | Tax (F) | −1,016 | -$4.2K | EDGAR |
| 2025-01-30 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-25 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2017-07-06 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −806 | -$1.9K | EDGAR |
| 2017-06-12 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-04 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −806 | -$4.1K | EDGAR |
| 2017-01-04 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −806 | -$6.2K | EDGAR |